Autism and Cord Blood

Video [Courtesy CNN]: Autism & Cord Blood Phase I Clinical Trial


Autism is a disorder that affects the brain's normal development of social and communication skills and appears in the first 3 years of life.103 Autism Spectrum Disorder (ASD) is a range of disorders characterized by “persistent deficits in social communication and social interaction across multiple contexts and restricted, repetitive patterns of behavior, interests, or activities.” Although the exact causes of Autism Spectrum Disorder are still unknown, research suggests that both genes and environment play important roles.102

SAVE $150 TODAY* with promo code: WBJUNE150  Enroll Online here or over the phone by tapping our phone number 866-668-4895.  Offer Ends 6/30.

In May 2014, the CDC published updated prevalence statistics. The data presented by the CDC reports that 1 in 68 children are identified with Autism Spectrum Disorder. And the data also showed that ASD is almost five times more common among boys than girls: 1 in 42 boys versus 1 in 189 girls.101  

Phase II Clinical Trial Underway

Duke University Medical Center has moved into a Phase II Clinical Trial of cord blood infusion for children with Autism Spectrum Disorder (ASD). The goal of the study is to determine if there is a benefit from an intravenous infusion of autologous (the child’s own) or unrelated donor cord blood to children with ASD. Visit to learn more about the study and requirements for participation.